Interserve Press Office | Jul 21, 2015
Interserve, the international support services and construction group, has been awarded a £35 million contract by Birmingham Children’s Hospital to design and build an exciting new clinical facility in central Birmingham.
The Steelhouse Lane facility will provide new and improved patient facilities for cancer, haematology and stem cell services, three theatres and 18 surgical beds, and a new rare diseases centre for children and young people.
The ProCure21+ (P21+) project, which is being designed in partnership with the hospital’s clinicians and architects BDP, is currently in the design phase with work due to start on site early in 2016 and completion expected during 2017.
Simon Butler, Interserve’s Divisional Director, said:
“We are delighted to have been selected to play such a key role in delivering a world class children’s hospital. As one of the official Principal Supply Chain Partners (PSCP) for P21+ we have extensive experience in the delivery of innovative and successful healthcare schemes and we are looking forward to working collaboratively with Birmingham Children’s Hospital.”
For further information please contact:
Interserve Press Office
Tel: 0118 932 0123
Karen Lewis or Peter Haddock
Tel: 01785 255146
Interserve is one of the world’s foremost support services and construction companies. Our vision is to redefine the future for people and places. Everything we do is shaped by our core values. We are a successful, growing, international business: a leader in innovative and sustainable outcomes for our clients and a great place to work for our people. We offer advice, design, construction, equipment, facilities management and frontline public services. We are headquartered in the UK and listed in the FTSE 250 index. We have gross revenues of £3.3 billion and a workforce of circa 80,000 people worldwide.
For all news follow: @interservenews